Clorox (NYSE:CLX) Price Target Cut to $132.00 by Analysts at Barclays

Clorox (NYSE:CLX - Get Free Report) had its price target dropped by equities research analysts at Barclays from $136.00 to $132.00 in a report issued on Thursday, Benzinga reports. The firm presently has an "underweight" rating on the stock. Barclays's target price suggests a potential downside of 5.49% from the stock's current price.

A number of other research analysts also recently issued reports on CLX. UBS Group reduced their price target on shares of Clorox from $164.00 to $159.00 and set a "neutral" rating on the stock in a research report on Wednesday. Morgan Stanley restated an "equal weight" rating and set a $160.00 target price on shares of Clorox in a report on Tuesday, March 26th. JPMorgan Chase & Co. decreased their target price on Clorox from $159.00 to $158.00 and set a "neutral" rating on the stock in a research report on Wednesday. Deutsche Bank Aktiengesellschaft lowered their target price on Clorox from $155.00 to $151.00 and set a "hold" rating on the stock in a research report on Wednesday, April 17th. Finally, Evercore ISI lowered their price target on Clorox from $145.00 to $142.00 and set an "underperform" rating on the stock in a report on Wednesday. Four investment analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company's stock. Based on data from MarketBeat.com, Clorox presently has an average rating of "Hold" and a consensus price target of $149.13.

Clorox Trading Up 0.0 %

Shares of NYSE:CLX traded up $0.04 during trading on Thursday, reaching $139.67. The company's stock had a trading volume of 2,055,399 shares, compared to its average volume of 1,264,719. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The stock has a market capitalization of $17.33 billion, a PE ratio of 73.06, a price-to-earnings-growth ratio of 2.34 and a beta of 0.44. The firm's 50 day simple moving average is $149.00 and its two-hundred day simple moving average is $143.10. Clorox has a 12 month low of $114.68 and a 12 month high of $178.21.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts' consensus estimates of $1.33 by $0.38. The business had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 305.36%. The business's revenue was down 5.3% on a year-over-year basis. During the same period last year, the company posted $1.51 EPS. On average, research analysts predict that Clorox will post 5.52 EPS for the current fiscal year.

Hedge Funds Weigh In On Clorox

Several institutional investors have recently bought and sold shares of CLX. Fortitude Family Office LLC acquired a new stake in shares of Clorox in the fourth quarter worth $29,000. Venturi Wealth Management LLC increased its position in shares of Clorox by 308.5% during the first quarter. Venturi Wealth Management LLC now owns 192 shares of the company's stock valued at $29,000 after acquiring an additional 145 shares during the last quarter. Northwest Financial Advisors purchased a new position in shares of Clorox in the fourth quarter valued at approximately $29,000. Core Wealth Advisors Inc. purchased a new position in Clorox in the fourth quarter worth approximately $29,000. Finally, First United Bank & Trust purchased a new stake in shares of Clorox during the 4th quarter worth approximately $31,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.